AQR Arbitrage’s NxStage Medical Inc. NXTM Stock Holding History

AQR Arbitrage’s Portfolio NXTM Stock Details NXTM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-3,684,861	Closed	-$105M	–	615
2018 Q4	$105M	Buy	3,684,861 +421,901	+13%	+$12M	1.45%	23
2018 Q3	$91M	Buy	3,262,960 +378,569	+13%	+$10.6M	1.05%	30
2018 Q2	$80.5M	Sell	2,884,391 -124,862	-4%	-$3.35M	0.99%	27
2018 Q1	$74.8M	Buy	3,009,253 +65,551	+2%	+$1.59M	0.87%	28
2017 Q4	$71.3M	Buy	2,943,702 +3,800	+0.1%	+$100K	0.84%	30
2017 Q3	$81.1M	Buy	+2,939,902	New	+$78.4M	0.88%	34

Other funds holding NXTM

TAL

TIG Advisors LLC New York $2.26B AUM 81.38% 1-Year Est. Return

AQR Arbitrage's NXTM Position: Q1 2019 in Review

AQR Arbitrage sold out of NxStage Medical Inc. (NXTM) in Q1 2019, closing a stake of 3,684,861 shares — an estimated $105M sold.

AQR Arbitrage first reported a position in NXTM in Q3 2017 and held it in 6 quarters. The position peaked at $105M in Q4 2018. 1 fund tracked by Wall St. Rank holds NXTM as of Q1 2019.

AQR Arbitrage reported no remaining NxStage Medical Inc. position as of Q1 2019 after selling out during the quarter.
AQR Arbitrage sold 3,684,861 NxStage Medical Inc. shares in Q1 2019, an estimated $105M.
AQR Arbitrage first reported a position in NxStage Medical Inc. in Q3 2017 and held it in 6 quarters.
AQR Arbitrage's NxStage Medical Inc. position peaked at $105M in Q4 2018.
1 fund tracked by Wall St. Rank held NxStage Medical Inc. as of Q1 2019.

Based on AQR Arbitrage's 13F filing for Q1 2019, filed 14 May 2019.